KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other financing activities (2018 - 2019)

Moderna (MRNA) has disclosed Other financing activities for 2 consecutive years, with -$3.7 million as the latest value for Q4 2019.

  • Quarterly Other financing activities fell 137.2% to -$3.7 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $13.6 million through Sep 2019, changed N/A year-over-year, with the annual reading at $22.0 million for FY2025, N/A changed from the prior year.
  • Other financing activities for Q4 2019 was -$3.7 million at Moderna, down from $3.7 million in the prior quarter.
  • The five-year high for Other financing activities was $9.9 million in Q4 2018, with the low at -$3.7 million in Q4 2019.